Atlantic Petroleum P/F
12.2.2021 12:08:06 CET | Globenewswire | Press release
Tórshavn, Faroe Islands, 2021-02-12 (GLOBE NEWSWIRE) -- P/F Atlantic Petroleum (NASDAQ OMX: ATLA DKK) hereby announces an update to the financial calendar for 2021 with the following dates:
- Wednesday 31st March: Annual Accounts 2020 to be issued.
- Friday 23rd April: Annual General Meeting.
- Monday 31st May: 1st Quarter 2021 Condensed Consolidated Interim Report to be issued.
- Tuesday 31st August: 2nd Quarter 2021 Condensed Consolidated Interim Report to be issued.
- Tuesday 30th November: 3rd Quarter 2021 Condensed Consolidated Interim Report to be issued.
Atlantic Petroleum in brief:
Atlantic Petroleum participates in oil and gas joint ventures with reputable, international partners. Atlantic Petroleum P/F is based in Tórshavn, Faroe Islands, and the Company has subsidiaries in UK and Ireland. Atlantic Petroleum’s existing shares are listed on NASDAQ OMX Copenhagen.
Further Details:
Further details can be obtained from Mark T. Højgaard, CEO (markh@petroleum.fo). This announcement will be available, together with other information about Atlantic Petroleum, on the Company's website: www.petroleum.fo.
Announcement no.3/2021
Issued 12-02-2021
P/F Atlantic Petroleum
Lucas Debesargøta 8
P.O. Box 1228
FO-110 Tórshavn
Faroe Islands
Website: www.petroleum.fo
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
King Faisal Specialist Hospital & Research Centre13.3.2026 22:15:53 CET | Press release
KFSH Leads Globally in Paired Kidney Transplants Performed at a Single Center in 2025
SCOR13.3.2026 18:59:39 CET | Press release
SCOR SE announces the availability of its 2025 Universal Registration Document
Novartis Pharma AG13.3.2026 18:35:19 CET | Press release
Novartis Cosentyx® receives FDA approval for pediatric patients aged 12+ with moderate to severe hidradenitis suppurativa
Luotea Oyj13.3.2026 18:30:00 CET | Press release
The Board of Directors of Luotea Oyj decided on updates to the company's share-based incentive plan for 2023-2027 and on the launch of a new share-based incentive plan for the years 2026-2030
Ilkka Oyj13.3.2026 18:00:00 CET | Press release
Ilkka Oyj: Acquisition of own shares on 13 March 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
